Doug Fisher, MD
Partner, Revelation Partners
Doug joined Revelation Partners in 2020 as a Partner. He is currently a board member of Aspen Neurosciences, Indi Molecular, Precipio Dx (NASDQA: PRPO), and WeavR Health. Since 2009, Doug has been a Partner and Venture Partner at InterWest Partners where he focused on biopharma and diagnostics companies including working as the CBO of Sera Prognostics (NASDAQ: SERA). Prior to joining InterWest, Doug was a vice president at New Leaf Venture Partners, Project Leader in the Healthcare Practice of The Boston Consulting Group, and a Marketing Associate at Centocor (J&J operating company). Doug received an A.B. in economics with honors and distinction, and a BS in biology with distinction, from Stanford, where he graduated Phi Beta Kappa. He has an MD from the University of Pennsylvania School of Medicine and an MBA from Wharton, where he graduated with honors as a Siebel Scholar and Palmer Scholar.